Pfizer, a big medicine company, had good news and bad news lately. They made a lot of money from their COVID vaccine and medicine, but sales are slowing down. They also have exciting new medicines in development, especially for weight loss, but face some challenges.
- Pfizer's COVID products still made billions of dollars.
- They are developing new medicines for weight loss and cancer.
- An investor group is questioning Pfizer's decisions.
- A new government official is skeptical of vaccines.
| Fact | Number |
|---|---|
| COVID product sales (2024) | $4.11 billion |
| Projected 2025 sales | $61-$64 billion |
| Pfizer's Stock Price Trend | Sideways movement |
